Profile cover photo
Profile photo
Baebies, Inc.
About
Baebies, Inc.'s posts

Post has attachment
Baebies has received FDA de novo clearance for the first lysosomal storage disease platform in newborn screening with SEEKER!

SEEKER is now the only platform on the market that has been authorized by the FDA to screen for enzyme deficiencies that might be indicative of Mucopolysaccharidosis Type I (MPS I), Pompe, Gaucher and Fabry disease.
Wait while more posts are being loaded